Skip to main content

DAVITA INC

For the period ended Mar 31, 2025. Filed May 12, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 12, 2025

DVA$191.35-1.8%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Income for the three months ended March 31, 2025 and March 31, 2024

CONSOLIDATED STATEMENTS OF INCOME

Three months ended March 31,
20252024
Dialysis patient service revenues$3,102,993$2,941,532
Other revenues120,536129,023
Total revenues3,223,5293,070,555
Operating expenses:
Patient care costs2,239,6602,078,976
General and administrative374,090362,480
Depreciation and amortization176,451187,083
Equity investment income, net(5,609)(6,682)
Gain on changes in ownership interests—(35,147)
Total operating expenses2,784,5922,586,710
Operating income438,937483,845
Debt expense(135,055)(99,418)
Other loss, net(17,549)(12,641)
Income before income taxes286,333371,786
Income tax expense54,11765,806
Net income232,216305,980
Less: Net income attributable to noncontrolling interests(69,299)(66,331)
Net income attributable to DaVita Inc.$162,917$239,649
Earnings per share attributable to DaVita Inc.:
Basic net income$2.05$2.73
Diluted net income$2.00$2.65
Weighted average shares for earnings per share:
Basic shares79,36887,775
Diluted shares81,27590,547
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.